A simple classification of cranial–nasal–orbital communicating tumors that facilitate choice of surgical approaches: analysis of a series of 32 cases by unknown
MISCELLANEOUS
A simple classification of cranial–nasal–orbital communicating
tumors that facilitate choice of surgical approaches: analysis
of a series of 32 cases
Yue-fei Deng1 • Bing-xi Lei1 • Mei-guang Zheng1 • Yi-qing Zheng2 •
Wei-liang Chen3 • Yu-qing Lan4
Received: 30 July 2015 / Accepted: 21 March 2016 / Published online: 26 March 2016
 The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract Cranial–nasal–orbital communicating tumors
involving the anterior and middle skull base are among the
most challenging to treat surgically, with high rates of
incomplete resection and surgical complications. Cur-
rently, there is no recognized classification of tumors with
regard to the choice of surgical approaches. From January
2004 to January 2014, we classified 32 cranial–nasal–or-
bital communicating tumors treated in our center into three
types according to the tumor body location, scope of
extension and direction of invasion: lateral (type I), central
(type II) and extensive (type III). This classification con-
siderably facilitated the choice of surgical routes and sig-
nificantly influenced the surgical time and amount of
hemorrhage during operation. In addition, we emphasized
the use of transnasal endoscopy for large and extensive
tumors, individualized treatment strategies drafted by a
group of multidisciplinary collaborators, and careful
reconstruction of the skull base defects. Our treatment
strategies achieved good surgical outcomes, with a high
ratio of total resection (87.5 %, 28/32, including 16 cases
of benign tumors and 12 cases of malignant tumors) and a
low percentage of surgical complications (18.8 %, 6/32).
Original symptoms were alleviated in 29 patients. The
average KPS score improved from 81.25 % preoperatively
to 91.25 % at 3 months after surgery. No serious periop-
erative complications occurred. During the follow-up of
3 years on average, four patients with malignant tumors
died, including three who had subtotal resections. The
3-year survival rate of patients with malignant tumors was
78.6 %, and the overall 3-year survival rate was 87.5 %.
Our data indicate that the simple classification method has
practical significance in guiding the choice of surgical
approaches for cranial–nasal–orbital communicating
tumors and may be extended to other types of skull base
tumors.
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Introduction
Tumors in the anterior and middle skull base and those in
the nasal cavity, sinuses and orbits frequently communicate
and reciprocally invade [1–3]. These tumors are among the
most challenging to treat surgically, with high rates of
incomplete resection, surgical complications and sequelae
owing to the involvement of functional structures, difficult
access and the creation of large dural and bone defects after
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the removal of the tumor [1–3]. The rate of surgical
complications in craniofacial tumor resections range from
33 to 50 % [4–6]. Selection of an appropriate surgical
approach with respect to the best perspective of exposure,
the shortest surgical distance and the lowest degree of brain
tissue stretch is a crucial issue in skull base surgery. A
literature review revealed more than 20 variations of sur-
gical approaches, which can be summarized as transcranial,
transfacial and a combined cranial–facial approach [7–10].
For cranial tumors located at the same location, there are
two or three surgically possible approaches, and the one
chosen varied greatly among different specialties [7–10].
For example, otolaryngologists may consider that the
combined craniofacial approach is the standard for skull
base tumors communicating with the nasal cavity [11];
however, neurosurgeons prefer the simple transcranial
approach that decreases surgical time without affecting the
efficacy and safety of surgery [8]. Several classification
methods of skull base tumors based on the site of tumor
origin and location or biological behavior (benign or
malignant) are available [12]. Similarly, a number of
classification methods have been adopted specifically for
malignant ethmoidal tumors [13]. These classifications
provide individualized guidance for specific types of
tumors, but have not formed a recognized standard for the
choice of surgical routes, particularly for cranial–nasal–
orbital communicating tumors.
From January 2004 to January 2014, we used a simple
classification method with regard to the location and
direction of tumor invasion to classify 32 cases of such
tumors treated in our center. This classification method
greatly facilitated the choice of surgical routes. In addition,
individualized strategies of tumor resection and skull base
defect repair based on pre- and perioperative pathological
findings were adopted by a group of multidisciplinary
collaborators from neurosurgery, oral and maxillofacial
surgery, otolaryngology and ophthalmology. The combined
strategy achieved ideal treatment efficacy with low rates of
complications and morbidity, and zero perioperative
deaths.
Materials and methods
The procedures of this study complied with the ethical
criteria of the Human Study Committee of Sun Yat-Sen
Memorial Hospital, Sun Yat-Sen University, Guangzhou,
China, and the study was approved by the same committee.
All patients agreed to the procedures and signed a written
informed consent form.
Inclusion criteria From January 2004 to January 2014,
our multidisciplinary collaborative group treated 32
patients with cranial–nasal–orbital tumors. All patients met
the following criteria:  15–75 years old and Karnofsky
score C70; ` no severe liver, kidney, lung, heart or other
organ dysfunction; ´ no previous history of anterior-me-
dial skull base tumor surgery or radiotherapy; ˆ pre-sur-
gical diagnosis confirmed by enhanced computed
tomography (CT), and magnetic resonance imaging (MRI)
showing that the scope of tumor invasion involved the
nasopharynx, orbit, ethmoid and cranial cavity simultane-
ously; and ˜ diagnosis of cranial–nasal–orbital communi-
cating tumors confirmed by intraoperative findings and
post-surgical histopathology.
Exclusion criteria Patients were excluded if they met the
following criteria: aged\15 years or[75 years; ` had a
fever or had obvious inflammation in the nasopharyngeal
skull; ´ had severe respiratory disease, heart disease,
kidney disease or blood system diseases; ˆ had a KPS
score less than 70; ˜ had a history of surgery or radio-
therapy of the skull base tumors.
Clinical data
The 32 patients included 20 males and 12 females with an
average age of 46.3 years (range 16–75 years). The aver-
age duration of disease was 11.2 months (range 2 weeks to
6 years). The average Karnofsky score was 81.25, includ-
ing 20 cases with a score of 80 and 8 cases with a score of
90. The pathological types of tumors are summarized in
Table 1, and the detailed symptoms are summarized in
Supplementary Table 1.
Table 1 Tumor types











Squamous cell carcinoma 3
Malignant fibrosarcoma 2
Lacrimal gland cell carcinoma 1
Melanoma 1
Transitional cell carcinoma 1
Small cell carcinoma 1
Transitional cell carcinoma 1
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Imaging examinations
All patients underwent CT and enhanced MRI before sur-
gery and at 1 and 6 months after surgery. For tumors with a
larger tumor body and abundant vascularization, 16
patients underwent magnetic resonance angiography
(MRA), 12 underwent digital subtraction angiography
(DSA) and 7 underwent external jugular vascular
embolization for vessels supplying the tumors before sur-
gery. There were 11 cases in which the main tumor body
was located laterally and 21 cases in which it was bilateral.
Seventeen cases exhibited expansion or disruption in the
optic nerve foramen or superior orbital fissure, and
destruction of the orbital roof, orbit or skull base bone was
found in all 32 cases. The average diameter of the tumors
was 5.7 cm (range 3–14.5 cm). In 12 cases, the diameter
was\4 cm, and in 20 cases it was C4 cm. The average
diameter of the skull base bone defects was 4.38 cm (range
3.3–7 cm).
The details about the tumor body location, extension/
invasion and the affected tissues are listed in Supplemen-
tary Table 4. As shown by CT and MRI, the major part of
tumor body in 15 cases was located at the skull base (SB):
12 at the anterior SB (3 left, 2 right, and 7 central SB), 1 at
both the anterior and middle SB and 2 at the junction of the
anterior and middle SB. In two patients, the major part of
tumor body was located at the sella or sella and the pet-
rocilivus. Thus, in 17 patients, the major part of tumors
were located in the intracranial cavity. For 12 patients, the
major part of tumor body was located extracranially, i.e.,
the orbits, nasopharynx and/or the nasal sinuses (ethmoid,
sphenoid, subfrontal); for 3 patients, the major part of
tumor body was located at both the SB and the orbits/nasal
sinuses. The locations of the major part of tumor body are
summarized in Supplementary Table 5.
Tumor classification
Based on pre-surgical CT and MRI imaging and periop-
erative observation, tumors were classified according to the
location of the main tumor body and the scope and direc-
tion of invasion (Table 2). The types were defined as
follows:
1. Type I or unilateral (n = 10). The main tumor body
was located at the same side of the nasopharynx and
ethmoid sinus and grew in an intracranial and intraor-
bital direction. The scope of invasion included one side
of the nasopharynx, ethmoid sinus, medial orbital wall,
1/2 of the external orbital roof and small wing of the
sphenoid bone (Fig. 1a–c).
2. Type II or central (n = 14). The main tumor body was
located at the center of the skull base (nasopharynx and
ethmoid sinus) and grew in an intracranial direction.
The scope of invasion included the frontal sinus,
ethmoid, 1/2 of the internal orbital roof or intraorbital
lateral wall and the planum sphenoidale (Fig. 2a–c).
3. Type III or extensive (n = 8). The tumor was massive
and located at the anterior-medial skull base, growing
extensively in a nasopharyngeal, intraorbital, and
intracranial direction. The scope of invasion was a
combination of the two previously described (Fig. 3a–c).
Treatment protocols
Pedicle flap preparation
A pre-surgical multidisciplinary meeting was organized,
and an individualized surgical plan was drafted for each
patient based on pathological features, imaging data and
tumor type. A scalp coronal or semicoronal incision was





Scope of tumor Invasion direction Surgical route
(approach)a
I: Lateral 10 Same side of the
nasopharynx and
ethmoid sinus
One side of nasopharynx, ethmoid sinus,
medial orbital wall, 1/2 of the external










Frontal sinus, ethmoid, 1/2 of the internal
















Surgical route: a total of 21 cases (2 unilateral, 12 central and 7 extensive) were combined with transnasal endoscopy (TNE)
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made at the hairline. Based on the requirements of skull
base repair, a skin flap was isolated from the superior or
inferior galea aponeurotica to the supraorbital margin [11]
and a pedicle flap of 12–14 cm 9 6–8 cm in size was
prepared for repair of the skull base defect. There were 5
pedicle frontal periosteal grafts, 3 pedicle flaps or peri-
cranial and galea aponeurotica flaps, and 24 pedicle galea
aponeurotica superior periosteal flaps.
Surgical routes, surgical approaches and tumor resection
The purpose of surgery was to remove as much tumor as
possible, whether benign or malignant, with complete
resection as the goal. Three surgical routes were adopted
based on the tumor classification: orbital-pterional, exten-
ded subfrontal and frontotemporal orbitozygomatic. For the
orbital-pterional route, the pterion was set as the center;
part of the supraorbital margin, the external orbital wall,
and part of the orbital roof were removed along with the
frontal-temporal flap. The resection range of the residual
supraorbital wall and a determination for the need of
grinding the superior orbital fissure and optic canal open
was based on the tumor location.
For the extended subfrontal route, a unilateral or bilat-
eral frontal flap was prepared, and the lower margin of the
flap was kept as close to the supraorbital margin as pos-
sible. Using a drill, some parts of the orbital roof,
supraorbital margin, nasofrontal fissure and nasal bone
were disconnected along with isolation of the frontal flap.
Isolation of the dura mater at the epidural region was made
as close to the posterior margin of the anterior cranial fossa
as possible.
Regarding the frontotemporal orbitozygomatic route, the
zygomatic arch was cut using a surgical saw from the upper
external to the lower internal regions. A complete flap was
constructed from the residual zygoma, supraorbital wall,
lateral orbital wall and frontotemporal bone and removed.
After flipping open the temporal muscle and removing the
external wall of the middle cranial fossa, the upper wall
and the external wall of the superior orbital fissure and the
upper wall of the optic nerve canal were removed by
grinding along the small wing of the sphenoid bone and
anterior clinoid process. A pedicle temporalis fascial flap
was prepared simultaneously.
In addition to the three routes, nasal endoscopy was used
in the combined craniofacial approach for 21 patients with
large malignant tumors, extensive invasion or huge benign
tumors in which the main body was located outside of the
skull for lateral rhinotomy on the basis of the aforemen-
tioned approaches.
Tumor resection
During surgery, important structures adjacent to the
tumors, including the internal carotid artery, cavernous
sinus, optic nerve, optic chiasm, pituitary and hypothala-
mus, were observed under high-power microscopy to avoid
injury. Intracranial tumors and tumors in the ethmoid sinus
were first removed through the intradural or subdural
pathway, followed by resection of tumors in the sphenoid
sinus, nasopharynx and intraorbital region. After removing
as much tumor as possible in the cranial area, a Karl Storz
endoscopic sinus surgery system (wide-angle endoscopes
of 0, 30 and 70 with a diameter of 4 mm and length of
Fig. 1 Unilateral lesion. A
48-year-old male presented with
a history of progressive
exophthalmos accompanied by
nasal congestion on the left side.
Biopsy of the nasopharyngeal
mass revealed a malignant
fibrosarcoma. a–c Preoperative
magnetic resonance imaging
(MRI) showed a tumor invading
the left nasopharynx, ethmoid
sinus and left orbit. d–f MRI
images 2 months after surgery
show that the tumor was
removed completely and the
skull base defect was repaired.
e The orbital-skull defect was
reconstructed with a titanium
mesh
2242 Eur Arch Otorhinolaryngol (2016) 273:2239–2248
123
18 cm) was used for further resection. The tumor was
isolated from one side of the nasal cavity where the main
tumor body resided and then resected from front to back
with a stripping tool, metal suction or tumor forceps with a
0 endoscope. Bleeding from the tumor or the anterior or
posterior ethmoid artery was electrocoagulated. For tumors
invading the maxillary sinus, the ipsilateral uncinate pro-
cess was removed to open the maxillary sinus and
Fig. 2 Central lesion. A
54-year-old male presented with
a history of headache and nasal




showed the tumor invading the
frontal–nasal–orbital region,
and the frontal bone at the
nasion was deformed. d–f MRI
images 3 months after surgery.
The tumor and the deformed
bone were removed, and the
reconstruction of the bone
defect was accomplished with a
titanium mesh
Fig. 3 Extensive lesion. A
48-year-old female presented
with a history of exophthalmos,
headache and vision loss. The




invasion of the anterior/middle
skull base, orbit, nasopharynx
and nasal cavity. d–f MRI
images taken 6 months after
surgery show that the tumor was
removed completely, and the
skull base defect was repaired.
e A titanium mesh was used to
repair the skull base defect
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sphenoid. Specific attention was paid to vital structures
including the orbital apex, optic nerve and carotid artery. If
difficulty was encountered, the bilateral nasal cavity
approach was used for resection and hemostasis. Finally,
the completeness of excision in the residual cavity of the
skull base was examined and repair of the skull base defect
was performed aided by nasal endoscopy.
Skull base defect repair
For the 20 patients with a skull base defect C4 cm in
diameter, the dura mater was repaired first with an artificial
meningeal patch (n = 14), isolated temporalis fascia
(n = 3) or periosteum (n = 3). Then, a previously pre-
pared pedicle flap was inverted backward and tiled on the
anterior skull base. The margin of the flap was sutured to
the dura mater at the skull base; deep areas which could not
be sutured were closed with biological glue. Finally, an
appropriately trimmed titanium mesh was placed between
the external dura mater and the flap for the repair of the
skull base bone defect. In seven patients with a large local
residual cavity (diameter[5 cm), the cavity was filled with
a previously prepared temporalis muscle flap.
For the 12 patients with a skull base defect diameter
\4 cm, the dura mater defect was repaired with an artificial
meningeal patch (n = 9), isolated temporalis fascia (n = 2)
or periosteum (n = 1), and the pedicle flap was attached to
the anterior skull base with sutures or biological glue.
Defects in the external cranial region were closed by
muscle paste prepared from temporal muscle retrieved
under nasal endoscopy. The paste was made my mashing
the retrieved muscle which was then used to fill the defect.
The wound was covered with a gelatin sponge and
filled/supported by an iodoform strip, both of which were
removed 1 week after surgery.
Postoperative management
A Pan’s drainage tube was placed deep in the surgical field
and was removed 3–5 days after surgery. A broad-spec-
trum antibiotic which easily passes through the blood–
brain barrier (ceftriaxone or cefotaxime combined with
metronidazole) was administered to all patients for 1 week.
Neurotrophic or antiepileptic medications were adminis-
tered as required. For 14 patients with malignant tumors,
radiotherapy alone or combined radiotherapy and
chemotherapy was administered. One case with a benign
tumor was treated with antiepileptic drugs and antibiotics.
Results
Effects of tumor classification and surgical
approaches on surgery
The surgical routes were chosen mainly based on the tumor
classification: the orbital-pterional route for lateral tumors
(type I); the extended subfrontal route for central tumors
(type II); for the extensive tumors (type III), the fron-
totemporal orbitozygomatic route was mainly adopted,
except in three cases for which the extended subfrontal
route was applied (Table 2). Significant differences in
operation time (P\ 0.001) and blood loss (P = 0.004)
during operation were observed among different tumor
classifications (Table 3) and different surgical routes based
on the classification (Table 4). The type I tumors and the
Table 3 Effects of tumor
classification on operation time
and blood loss
Type of tumor F P
Lateral Central Extensive
# of cases 10 14 8
Operation time (h) 4.68 ± 0.8 5.3 ± 0.6 6.1 ± 0.45 13.983 \0.001
Blood loss (ml) 313 ± 134.6 387.9 ± 96.7 510 ± 107.3 6.898 0.004
Statistical difference was determined using one-way ANOVA analysis
Table 4 Effects of surgical routes on operation time and blood loss
Surgical approaches F P
Orbital-pterional Extended subfrontal Frontotemporal orbitozygomatic
# of cases 10 17 5
Operation time (h) 4.68 ± 0.8 5.4 ± 0.63 6.3 ± 0.29 10.687 \0.001
Blood loss (ml) 313 ± 134.6 395.9 ± 89.6 556 ± 112.6 8.343 0.001
Statistical difference was determined using one-way ANOVA analysis
2244 Eur Arch Otorhinolaryngol (2016) 273:2239–2248
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corresponding orbital-pterional route had the shortest
operation time and lowest blood loss during operation,
while the type III tumor and the frontotemporal orbitozy-
gomatic route had the longest operation time and the
highest blood loss. These data indicate that the classifica-
tion method and the corresponding surgical routes exerted
significant impact on surgery. In comparison, the tumor
size (tumor volume) was not significantly correlated with
the operation time (P = 0.09) or the amount of blood loss
during surgery (P = 0.29) (Table S3).
Overall surgical outcomes
Total resection of tumors was achieved in 28/32 patients
(87.5 %). There were no perioperative deaths. The average
operative time was 5.3 h (range 4–6.6 h), and the average
blood loss was 395 ml (range 130–700 ml). Outcomes
were determined by combining microscopy observation
during surgery and postoperative head CT and MRI
(Figs. 1, 2, 3d–f). Of 17 patients with benign tumors, 16
had complete tumor removal and 1 had subtotal resec-
tion. Of the 15 patients with malignant tumors, 12 had
complete tumor resection and 3 had subtotal resection. The
tumor classification, the corresponding surgical approaches
and outcomes of individual cases are listed in Supple-
mentary Table 1.
Clinical improvement after surgery
In all 32 patients, original symptoms were alleviated after
surgery, and nasal obstruction, exophthalmos, head dis-
tending pain and local craniofacial malformation disap-
peared. Alleviation of symptoms of diplopia in 12 cases,
hypoplasia in 9 cases and visual field defects in 9 cases
were observed. No changes were noted in olfactory
degeneration and facial paralysis. The quality of life was
significantly improved after surgery. The average Karnof-
sky score evaluated 3 months after surgery was signifi-
cantly higher (91.25) than that before (81.25) (P\ 0.001),
including 12 cases with a score of 100, 12 cases with 90
and 8 cases with 80.
Surgical complications
Oculomotor nerve palsy was observed at an early stage in
four patients. Two patients had hypoplasia. Rhinorrhea was
noted in three patients after the removal of the iodoform strip
and resolved after cerebrospinal fluid drainage by lumbar
cannulation for 1 week. No severe complications occurred
after surgery, such as neurologic impairment, pneumo-
cephalus, meningoencephalocele and intracranial infection.
The overall surgical complication rate was 18.8 %.
Follow-up
All 32 patients were followed up in outpatient clinics,
and the average duration of follow-up was 2.99 years
(range 6 months to 7 years). Patients with malignant
tumors received radiotherapy and chemotherapy as
adjuvant treatments. Of the patients with benign tumors,
two patients with meningioma relapsed and were treated
by gamma knife radiotherapy. Four patients with
malignant tumors died, including three who had subtotal
resections. One patient with esthesioneuroblastoma died
from chemotherapy-induced liver failure at 6 months
after surgery. The patients with fibrosarcoma, lacrimal
cell carcinoma and transitional cell carcinoma died
from intracranial and multiple systemic metastases
within 3 years after surgery. As a result, the 3-year
survival rate for patients with malignant tumors was
78.6 % (11/14) and the overall 3-year survival rate was
87.5 %. One patient with an invasive pituitary tumor
received radiotherapy to prevent a recurrence and had
transient cerebrospinal fluid leakage 2 months after





Cranial–nasal–orbital communicating tumors involving
the paranasal sinuses, intracranial cavity and orbit are
particularly difficult for surgical removal, presenting
challenges for skull base reconstruction and a greater
risk of post-surgical complications due to a greater range
of lesion invasion [2, 3, 9, 14]. Skull base tumors can be
classified according to the site of the tumor origin, tumor
location (anterior, middle or posterior skull base) and the
biological behavior (benign, low-grade or high-grade
malignancy) [12]. These methods of classification pro-
vided differential guidance for surgical treatments of
each specific type of tumor. To date, however, no clas-
sification has been specifically aimed to facilitate the
selection of surgical approaches, and no classification is
available for cranial–nasal–orbital communicating
tumors [2, 4, 15]. In this investigation, we have classi-
fied 32 cases of communicating tumors (17 benign and
15 malignant) from our institution into three types on the
basis of tumor location, extension and direction of
invasion: lateral, central and extensive. Below, we dis-
cuss the feasibility of this classification in clinical
practice.
Eur Arch Otorhinolaryngol (2016) 273:2239–2248 2245
123
Classification facilitates selection of surgical routes
We designed the corresponding surgical approaches to
achieve maximum exposure, the shortest surgical distance,
the lowest degree of brain tissue stretch, the complete
removal of the tumors with minimum operation time and
blood loss, and the lowest operative complications. There
are three major routes corresponding to the three types of
tumors we have classified (Table 2): orbital-pterional,
extended subfrontal, and frontotemporal orbitozygomatic
corresponding to type I (lateral), II (central) and III (ex-
tensive), respectively. However, in three cases of type III,
the extended subfrontal approach was applied for consid-
eration of the specific features of the tumors. Overall, the
classification and the corresponding surgical approaches
exerted significant influence on the operation time and the
blood loss during surgery (Tables 3, 4). The analysis val-
idates the feasibility of our classification method, providing
substantial guidance for future clinical practice to avoid
unnecessarily complicated procedures requiring long
operation times, resulting in excess blood loss and possibly
tissue damage. As this classification and the corresponding
choice of surgical approaches are based on the tumor
location, scope of extension and the direction of invasion
regardless of the pathological phenotypes or tissue origin, it
may also be applicable to other types of skull base tumors.
Selection of tumor resection for cranial–nasal–
orbital communicating tumors
As described above, the selection of surgical approaches
was mainly based on the classification of the tumors, as
determined by the location of the tumor main body and the
extent and direction of invasion/extension. Nevertheless,
the pathological data obtained before and during surgery
helped determine the extent of surgical resection. The
benign tumors were resected along the border as far as
possible with the assistance of an endoscope. Malignant
tumors were resected as much as possible according to the
principle of protecting and preserving the function of the
surrounding organs/tissues.
For large tumors with the main tumor body located in
the extracranial space and malignant tumors with invasive
growth to a wider area, complete exposure is difficult to
achieve. The use of the combined craniofacial approach
has become conventional and widely used for resection of
skull base tumors in a deep location and with a large
scope of extension [4, 11, 16], including communicating
tumors [17, 18]. The use of transnasal endoscopy has
become a standard and it is critical for the success of the
craniofacial approach, as it can be used to determine the
extent of the tumor and observe for the presence of
residual tumor to thoroughly remove the tumor invading
the anterior and middle cranial fossa en bloc. Meanwhile,
it helps protect important neurovascular structures,
reconstruct the skull base and prevent cerebrospinal fluid
leakage. The technique of decompression of the optic
canal, repair of cerebrospinal rhinorrhea and hypophy-
sectomy with the aid of a transnasal endoscope has been
well developed, and the application has been extended to
the removal of meningiomas and chordomas [3, 8, 19–21].
However, with the combined transcranial and transnasal
approach, the brain tissue is often pulled obviously,
resulting in severe cerebral edema after the operation.
Therefore, of the 32 cases in our study, 11 patients with
the tumor body located mainly in the cranial space were
treated by the simple transcranial approach, which was
sufficient to fully expose and resect intracranial tumors.
The other 21 were treated by the combined craniofacial
approach with the aid of transnasal endoscopy. Among
them, 2 underwent lateral rhinotomy to remove the mas-
sive tumor located in the extracranial region and the other
19 patients underwent extracranial tumor resection
through a unilateral or bilateral nasal opening via endo-
scopy. In addition, the individualized surgical protocol
drafted by the multidisciplinary group for each patient is
also critical for the success of the surgical treatment.
Through these approaches, radical resection was achieved
in 87.5 % of the patients (28/32), with a low rate of
complications, no perioperative deaths or new neurolog-
ical defects. The overall surgical outcome is ideal.
Treatment of post-surgical skull base defects
Various degrees of damage to the dura mater at the skull
base and cranial bone are found after removing the cranial–
nasal–orbital communicating tumors. A skull base defect
results in the communication of brain tissue with the orbit,
ethmoid sinus and even nasopharynx, which can lead to
severe complications including cerebrospinal fluid leakage,
intracranial infection, pneumocephalus and meningoen-
cephalocele [9]. Cerebrospinal fluid leakage occurs in
5.7–30 % of tumors at the midline region of the skull base
when treated with the endoscopic transnasal approach [19,
22]. Thus, the reconstruction of the skull base defect has
been considered a key in successful skull base tumor sur-
gery [9, 14, 23–26]. Currently, there are no recognized
standards for the selection of materials and methods for
repairing a skull base defect after surgery. Materials for
repair are mainly divided into two major categories: arti-
ficial synthetic materials and autologous biologic materials.
The former are mainly titanium ethmoid sinus plates and
artificial dura mater patches, and the latter includes cal-
varium and a variety of isolated or vascularized periosteal
flaps. The effects of different materials and methods for
repairing an anterior skull base defect are not consistent,
2246 Eur Arch Otorhinolaryngol (2016) 273:2239–2248
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and the occurrence rate of complications has been reported
to range from 0 to 21.9 % [27, 28].
In this study, the following principles were complied
with: (1) Dura mater defects of 1 cm 9 2 cm or less in size
at the skull base were repaired with isolated periosteum and
a temporalis fascia flap. For deep regions where sutures
could not be applied, a combination of temporal muscle
paste and fibrin glue was used. (2) Skull base bone defects
with a diameter\4 cm were closed by a pedicle flap on the
anterior skull base, which was fixed to the dura mater by
sutures or biological glue. For defects with a diame-
ter C4 cm or for those that affected the appearance, a
pedicle flap was placed on the anterior skull base and
sutured or fixed with biological glue, followed by place-
ment of a titanium mesh between the outer dura mater and
pedicle flap. The depth of the cavity was filled by an
elongated temporalis muscle flap. In the extracranial
region, the defect was covered by muscle paste and a
gelatin sponge under nasal endoscopy, and supported by an
iodoform strip, which was removed 1 week after surgery.
Using this repair method, no complications occurred after
hospital discharge.
For surgical treatment, the difference between benign
and malignant tumors is of less impact, as the surgical
strategy was always to remove as much of the lesion as
possible with the goal of complete resection. The man-
agement methods we have described are applicable to both
malignant and benign tumors, and the outcomes of the 32
patients indicate that it is practical for preoperative clas-
sification of communicating tumors regardless of their
benign or malignant nature.
Our study has limitations. The sample size is small, and
our classification did not take into account the difference
between benign and malignant tumors. Thus, in future
studies, we need to increase the number of cases from
multiple institutions. Moreover, preoperative biopsy for
pathological diagnosis would be essential for making a
more precise classification by considering the difference
between benign and malignant tumors.
Conclusions
We classified 32 cases of cranial–nasal–orbital commu-
nicating tumors into three main types according to the
tumor body location, the scope of extension and the
direction of invasion. The classification facilitated the
choice of surgical routes, exerting significant impact on
surgical time and the amount of hemorrhage during
operation. Combined with individualized strategies
developed by a multidisciplinary group and the aid of
nasal endoscopy for large and extensive tumors, as well
as carefully designed skull base reconstruction, ideal
surgical outcomes were achieved, with low complication
and morbidity rates, zero perioperative deaths and a high
3-year survival rate of patients with malignant tumors
(73.3 %; 11/15). As the simple classification method is
based on the general properties of the tumors (location,
scope of extension and invading direction) rather than the
specific pathological or tissue types, it may also be
applicable to other types of skull base tumors.
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